A Review on Novel Drug Targets and Future Directions for COVID-19 Treatment

Yohannes Tsegyie Wondmkun1, Ousman Ahmed Mohammed2

  • 1Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

Insights

This review identifies key drug targets for COVID-19, including viral proteins and host pathways like JAK/STAT. It highlights antiviral strategies and drug repurposing for developing new treatments and vaccines against SARS-CoV-2.

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes a global pandemic, necessitating rapid understanding of its mechanisms.
  • Research efforts focus on identifying viral characteristics and disease pathogenesis to discover therapeutic interventions and vaccines.
  • Numerous potential drug targets have been proposed by scientists to combat the virus.

Purpose of the Study:

  • To review and summarize promising drug targets for COVID-19.
  • To highlight antiviral strategies involving molecular interactions for drug repurposing.
  • To provide a rational basis for the discovery of novel drugs and vaccines.

Main Methods:

  • Literature review of identified drug targets for SARS-CoV-2.
  • Analysis of antiviral strategies based on molecular interactions.
  • Examination of host-specific factors and viral components as therapeutic targets.

Main Results:

  • Identified drug targets include structural glycoproteins, virulence factors, host receptors/enzymes, non-structure proteins, the JAK/STAT pathway, and pro-inflammatory cytokines.
  • Antiviral strategies focus on repurposing existing drugs through molecular interactions with viral and host machinery.
  • The review provides a foundation for ongoing drug and vaccine development.

Conclusions:

  • Several key targets and strategies show promise for COVID-19 treatment and prevention.
  • Drug repurposing offers a viable approach to rapidly address the pandemic.
  • Continued research into molecular targets is crucial for developing effective new therapies and vaccines.

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
749
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.5K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K